Back
MiNK Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
INKT
MiNK Therapeutics
Last Price:
$26.20
Seasonality Move:
1.4%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
MiNK Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.14 | Sell |
20-day SMA: | 13.67 | Buy |
50-day SMA: | 9.85 | Buy |
200-day SMA: | 8.33 | Buy |
8-day EMA: | 23.59 | Sell |
20-day EMA: | 13.6 | Buy |
50-day EMA: | 6.38 | Buy |
200-day EMA: | 1.73 | Buy |
MiNK Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.05 | Buy |
Relative Strength Index (14 RSI): | 55.1 | Buy |
Chaikin Money Flow: | -885507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-0.77 - 25.65) | Buy |
Bollinger Bands (100): | (2.15 - 15.99) | Buy |
MiNK Therapeutics Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for MiNK Therapeutics Stock
Is MiNK Therapeutics Stock a Buy?
-
MiNK Therapeutics share price is 23.11 while INKT 8-day simple moving average is 23.14, which is a Sell signal.
-
The stock price of INKT is 23.11 while MiNK Therapeutics 20-day SMA is 13.67, which makes it a Buy.
-
MiNK Therapeutics 50-day simple moving average is 9.85 while INKT share price is 23.11, making it a Buy technically.
-
INKT stock price is 23.11 and MiNK Therapeutics 200-day simple moving average is 8.33, creating a Buy signal.
INKT Technical Analysis vs Fundamental Analysis
Sell
46
MiNK Therapeutics (INKT)
is a Sell
Is MiNK Therapeutics a Buy or a Sell?
-
MiNK Therapeutics stock is rated a SellThe current MiNK Therapeutics [INKT] share price is $23.11. The Score for INKT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
MiNK Therapeutics Stock Info
Market Cap:
92.1M
Price in USD:
23.11
Share Volume:
885.5K
MiNK Therapeutics 52-Week Range
52-Week High:
76.00
52-Week Low:
4.56
Sell
46
MiNK Therapeutics (INKT)
is a Sell
MiNK Therapeutics Share Price Forecast
-
What is the MiNK Therapeutics stock price today?The MiNK Therapeutics stock price is 23.11 USD today.
-
Will INKT stock go up or go down?MiNK Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MiNK Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MiNK Therapeutics is overvalued.
Is MiNK Therapeutics Stock a Buy?
-
MiNK Therapeutics share price is 23.11 while INKT 8-day exponential moving average is 23.59, which is a Sell signal.
-
The stock price of INKT is 23.11 while MiNK Therapeutics 20-day EMA is 13.60, which makes it a Buy.
-
MiNK Therapeutics 50-day exponential moving average is 6.38 while INKT share price is 23.11, making it a Buy technically.
-
INKT stock price is 23.11 and MiNK Therapeutics 200-day simple moving average is 1.73, creating a Buy signal.
Fundamental Analysis of MiNK Therapeutics
Is MiNK Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.69 per share, and an increase next year of $0.13 per share.
Technical Analysis of MiNK Therapeutics
Should I short MiNK Therapeutics stock?
-
INKT Moving Average Covergence Divergence (MACD) indicator is 8.05, suggesting MiNK Therapeutics is a Buy
-
MiNK Therapeutics Relative Strength Index (RSI) is 55.1, which suggest MiNK Therapeutics is overbought
-
The Bollinger Bands (25) for MiNK Therapeutics is (-0.77 - 25.65), which suggest MiNK Therapeutics is a Buy
-
The Bollinger Bands (100) for MiNK Therapeutics is (2.15 - 15.99), which suggest MiNK Therapeutics is a Buy
* MiNK Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.